R2AR34 / Ultragenyx Pharmaceutical Inc. - Depositary Receipt (Common Stock) - Ai+ Enhanced Message Board

Ultragenyx Pharmaceutical Inc. - Depositary Receipt (Common Stock)

BR ˙ BOVESPA

30,57 BR$ ↓ −1,38 (−4,32%)

2024-10-22
DELAT PRIS

Share Your Thoughts or Ask a Question

Titel Text Berätta vad du har att säga. Du kan inkludera länkar, men inte *bara* länkar. Dela dina omtänksamma åsikter. Använd Markdown .

Using Standard

Fintel data has been cited in the following publications:

© 2015-2025 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.